Comparison of clinical outcomes following small incision lenticule extraction performed with the visumax 800 versus visumax 500 femtosecond laser
Bu Ki Kim, Young Taek Chung
Scientific Reports · 2025
doi:10.1038/s41598-025-98041-9 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract This study compared clinical outcomes between small incision lenticule extraction (SMILE) procedures performed with the Visumax 800 and Visumax 500 femtosecond lasers. We compared the clinical outcomes of 100 eyes of 50 patients who underwent SMILE using the Visumax 800 (SMILE Pro group) and 100 eyes of 50 patients who underwent SMILE using the Visumax 500 femtosecond laser (SMILE group). Outcomes were assessed at a 3-month follow-up, including standard visual outcomes, optic zone decentration, and corneal higher-order aberrations (HOAs). The mean lenticule creation time was significantly shorter in the SMILE Pro group (10.33 ± 0.82 s) than the SMILE group (28.27 ± 2.34 s, P < 0.001). At 3 months postoperatively, the groups had no significant differences in uncorrected or corrected distance visual acuity, residual refractive errors, or corneal HOAs. However, the optic zone decentration was significantly smaller in the SMILE Pro group than in the SMILE group (P < 0.001), and the vertical coma induction was significantly lower in the SMILE Pro group compared with the SMILE group (P = 0.034), suggesting that the Visumax 800 provides enhanced centration accuracy, reduced vertical coma induction, and faster lenticule creation, demonstrating comparable efficacy, safety, and predictability to the Visumax 500.
Abstract licence: CC BY-NC-ND
References28
28 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.